This paper attempts to summarize current knowledge about immune responses to vaccines
that correlate with protection. Although the immune system is redundant, almost all current …

Abstract This is a Brighton Collaboration Case Definition of the term “Vaccine Associated
Enhanced Disease” to be utilized in the evaluation of adverse events following …

The immune system is redundant, and B and T cells collaborate. However, almost all current
vaccines work through induction of antibodies in serum or on mucosa that block infection or …

Forty years after effective vaccines were licensed, measles continues to cause death and
severe disease in children worldwide. Complications from measles can occur in almost …

Measles remains an important cause of child morbidity and mortality worldwide despite the
availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was …

Measles remains a leading vaccine-preventable cause of child mortality worldwide,
particularly in sub-Saharan Africa where almost half of the estimated 454,000 measles …

Immunizing infants against measles at the youngest age possible has the potential to reduce
morbidity and mortality. The ability of infants at 6, 9, or 12 months to respond to measles and …

Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic
option for solid and hematologic malignancies. A considerable variety of viruses ranging …

Conditionally replicating viruses are promising agents for the treatment of malignancy. Here
it is shown that the live attenuated Edmonston-B vaccine strain of measles virus (MV-Edm) …

In the 1960s, a formalin-inactivated measles vaccine (FIMV) predisposed recipients to
atypical measles, an immune complex–mediated disease,. To identify characteristics of the …